EQUASENS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.9 EUR | -0.67% |
|
+2.08% | -3.60% |
| 04-02 | Equasens : RNPG virtually stable in 2023 | CF |
| 03-29 | Equasens Société Anonyme Provides Revenue Guidance for the 2025 | CI |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an enterprise value anticipated at 3.81 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: IT Services & Consulting
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -3.60% | 947M | - | ||
| -14.93% | 189B | A- | ||
| +0.72% | 166B | B+ | ||
| +1.07% | 152B | B- | ||
| +8.08% | 99.37B | A- | ||
| +5.95% | 77.36B | A- | ||
| +14.30% | 70.76B | C- | ||
| -7.93% | 70.46B | A | ||
| -21.86% | 51.83B | C | ||
| -6.79% | 44.34B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EQS Stock
- Ratings Equasens
